Table 5.
Association of DGX application methods with new-onset AF in RHD patients.
| New-onset AF | Before PSM | After PSM | |||||
|---|---|---|---|---|---|---|---|
| Events (N/%) | OR (95% CI) | P -value | Events (N/%) | OR (95% CI) | P -value | ||
| Unadjusted model | iDGXUD | 91 (40.3) | Ref. | 84 (41.6) | Ref. | ||
| cDGX | 123 (57.2) | 1.98 (1.36–2.90) | <0.001 | 105 (56.1) | 1.80 (1.20–2.69) | 0.004 | |
| Model 1a | iDGXUD | 91 (40.3) | Ref. | 84 (41.6) | Ref. | ||
| cDGX | 123 (57.2) | 1.73 (1.12–2.68) | 0.014 | 105 (56.1) | 1.96 (1.07–3.58) | 0.028 | |
| Model 2b | iDGXUD | 91 (40.3) | Ref. | 84 (41.6) | Ref. | ||
| cDGX | 123 (57.2) | 1.58 (1.03–2.44) | 0.038 | 105 (56.1) | 1.94 (1.05–3.57) | 0.034 | |
| Model 3c | iDGXUD | 91 (40.3) | Ref. | 84 (41.6) | Ref. | ||
| cDGX | 123 (57.2) | 1.61 (1.03–2.52) | 0.036 | 105 (56.1) | 2.06 (1.09–3.90) | 0.027 | |
Model 1: adjusting for baseline adjustment covariates, including age, gender, smoking, drinking, disease duration, NYHA, cardiac valve damage, surgical intervention, medical condition (HT, CHD, T2D, AF at enrolment, and stroke), blood biochemical index (WBC, HGB, PLT, FBG, ALT, AST, Cr, ASO, RF, ESR, BNP, TRIG, TC, LDL-C, HDL-C, serum sodium, and serum potassium), and echocardiography (LAD, LVD, RVD, RAD, and LVEF).
Model 2: It was the same as model 1 and also included combined medication (antiplatelet drugs, warfarin, digoxin, nitrates, RSIs, BBs, MRAs, CCBs, and statins).
Model 3: It was the same as model 2 and also included SDC.
The bold values mean P value < 0.05.